01 6Reminyl
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 164
2018 Revenue in Millions : 155
Growth (%) : 5
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 95
2019 Revenue in Millions : 167
Growth (%) : -43
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 0
2020 Revenue in Millions : 91
Growth (%) : -100
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 155
2015 Revenue in Millions : 143
Growth (%) : 8
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 172
2016 Revenue in Millions : 165
Growth (%) : 4
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 150
2017 Revenue in Millions : 161
Growth (%) : -7%
LOOKING FOR A SUPPLIER?